Literature DB >> 35949829

De novo brain arteriovenous malformation formation and development: A case report.

Huan Huang1, Xue Wang1, An-Na Guo1, Wei Li2, Ren-Hua Duan2, Jun-Hao Fang2, Bo Yin2, Dan-Dong Li3.   

Abstract

BACKGROUND: Brain arteriovenous malformation (AVM), an aberrant vascular development during the intrauterine period, is traditionally considered a congenital disease. Sporadic reports of cases of de novo AVM formation in children and adults have challenged the traditional view of its congenital origin. CASE
SUMMARY: In this report, we have presented the case of a child with a de novo brain AVM. Magnetic resonance imaging and magnetic resonance angiography of the brain showed no AVM at the age of 5 years and 2 mo. Brain AVM was first detected in this child at the age of 7 years and 4 mo. The brain AVM was significantly advanced, and hemorrhage was seen for the first time at the age of 12 years and 8 mo. There was further progression in the AVM, and hemorrhage occurred again at the age of 13 years and 5 mo. Genetic analysis of this patient revealed a mutation in the NOTCH2 (p.Asp473Val) gene.
CONCLUSION: In short, our case has once again confirmed the view that brain AVM is an acquired disease and is the result of the interaction of genes, environment, and molecules. ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Case report; De novo arteriovenous malformation; Hemorrhage; NOTCH2

Year:  2022        PMID: 35949829      PMCID: PMC9254196          DOI: 10.12998/wjcc.v10.i18.6277

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.534


Core Tip: Brain arteriovenous malformation (AVM) is one of the main causes of spontaneous cerebral hemorrhage in children. At present, the mechanism of the occurrence and development of AVM is not clear, and there have been very few case reports that have documented the progression of a de novo brain AVM. In this report, we present the case of a child with a de novo brain AVM. Brain AVM was first detected in this child at the age of 7 years and 4 mo and was significantly advanced and hemorrhaging at the age of 12 years and 8 mo. Genetic analysis of this patient revealed a mutation in the NOTCH2 (p.Asp473Val) gene.

INTRODUCTION

Brain arteriovenous malformation (AVM) is one of the main causes of spontaneous cerebral hemorrhage in children[1] and accounts for 30%-50% of spontaneous cerebral hemorrhage in children[1,2]. It is generally believed that AVM is a kind of congenital vascular disease[3]. The abnormality is formed in the third to fourth week of embryonic development, when the length is about 40-80 mm, during the process of cerebrovascular development and manifests as abnormal coiled and interlaced vascular clusters[4]. Arteries and veins are directly connected by malformed vascular clusters. At present, the mechanism of the occurrence and development of AVM is not clear, and there have been very few case reports that have documented the progression of a de novo brain AVM[5-7]. Here, we have documented for the first time a case of a child with a de novo brain AVM that progressed and ruptured twice within 6 years. We have also reported for the first time the potential role of heterozygous mutations in the NOTCH2 gene in the pathogenesis of AVM.

CASE PRESENTATION

Chief complaints

A 15-year-old boy was admitted to the hospital in November 2019 with complaints of an acute headache for 3 h.

History of present illness

The child presented with a sudden severe headache for 3 h with no inducing factors. He was conscious and had no history of nausea, dizziness, or fever.

History of past illness

The boy had normal growth and development and no history of other special diseases. In August 2011, the child presented at another hospital with complaints of a headache for more than 1 wk. At that time, magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), and magnetic resonance venography (MRV) were performed. The scans revealed that there was no vascular abnormality, abnormal signal intensity, or any other findings suggestive of an AVM (Figure 1A-C). At that time, the doctor did not administer any treatment, and the headache was ameliorated by itself. In October 2013, the child again presented at another hospital with headache and nausea for 2 d. His MRA scan revealed a small right temporal AVM, the size of which was 6.2 mm × 1.9 mm (Figure 1C). Digital subtraction angiography revealed the presence of a suspicious lesion in the right temporal lobe (Figure 1D). The boy was treated for headaches and was not examined further. In February 2019, the boy presented at our hospital complaining of a sudden headache and vomiting for 2 h. He was conscious when he came to our hospital. His Glasgow coma scale score was 14, and National Institutes of Health Stroke Scale score was 1. Computed tomography of the head demonstrated acute intracerebral hemorrhage in the right temporal lobe. The MRA revealed a small AVM in the right temporal lobe (Figure 1E). Symptomatic treatment was given to the child during hospitalization, and gamma knife radiosurgery was suggested. Unfortunately, the child’s parents rejected radiotherapy.
Figure 1

Diagnostic images from August 2011 to November 2019. A-C: T1 (A) and T2 (B) weighted images of magnetic resonance imaging, and (C) magnetic resonance angiography (MRA) done in August 2011, at the age of 5 years and 2 mo. There is no evidence of vascular lesion; D and E: The results of (D) MRA and (E) the first anteroposterior digital subtraction angiography (DSA) performed in October 2013, indicating de novo arteriovenous malformation; F-H: The results of (F) the head computed tomography (CT) scan, (G) MRA, and (H) the second DSA, which were performed in February 2019; I and J: Results from (I) the post-hemorrhage non-contrast head CT scan depicting blood in the right temporal lobe and (J) the third DSA, which were performed in November 2019.

Diagnostic images from August 2011 to November 2019. A-C: T1 (A) and T2 (B) weighted images of magnetic resonance imaging, and (C) magnetic resonance angiography (MRA) done in August 2011, at the age of 5 years and 2 mo. There is no evidence of vascular lesion; D and E: The results of (D) MRA and (E) the first anteroposterior digital subtraction angiography (DSA) performed in October 2013, indicating de novo arteriovenous malformation; F-H: The results of (F) the head computed tomography (CT) scan, (G) MRA, and (H) the second DSA, which were performed in February 2019; I and J: Results from (I) the post-hemorrhage non-contrast head CT scan depicting blood in the right temporal lobe and (J) the third DSA, which were performed in November 2019.

Personal and family history

The patient did not have any personal or family history of brain AVM.

Physical examination

The patient was conscious when examined at our hospital in November 2019. His Glasgow coma scale score was 15 and his National Institutes of Health Stroke Scale score was 1.

Laboratory examinations

Laboratory examinations showed no significant abnormality.

Imaging examinations

A small AVM within the right temporal lobe was visualized in the MRA (Figure 1G), and cerebral angiogram revealed the presence of a 21.6 mm × 21.2 mm right temporal AVM, which was supplied by the inferior temporal branches of the right posterior cerebral artery. Venous drainage occurred through superficial cerebellar veins into the right sigmoid sinus. It was classified as Spetzler-Martin grade 1 (Figure 1H). In November 2019, computed tomography of the head demonstrated the presence of an acute intracerebral hemorrhage in the right temporal lobe (Figure 1I). Digital subtraction angiography displayed abnormal vascular clusters, which were slightly larger than those seen 10 mo ago. The size of these clusters was 24.3 mm × 22.8 mm. The AVM was classified as a Spetzler-Martin grade 1 (Figure 1J).

Further diagnostic work-up

After receiving consent from the child’s parents, we conducted genetic analysis for the child and his parents. We discovered a mutation that might be related to the incidence of AVM, NOTCH2 heterozygous mutation [NM_024408.3; c.1418A>T; p.Asp473Val]. The mutation was only found in the child.

FINAL DIAGNOSIS

Brain AVM, Spetzler-Martin grade 1.

TREATMENT

The parents refused to conduct further interventional treatment. Supportive treatment was administered during the hospitalization period, and the boy was discharged after 10 d in good clinical condition.

OUTCOME AND FOLLOW-UP

The clinical condition of the child was good during the final follow-up, which was performed on January 2021. The child was in good general condition at the time. After January 2021, he was lost to follow-up.

DISCUSSION

The patient underwent MRI, MRA, and MRV scans in August 2011, at the age of 5 years and 2 mo for nonspecific headaches. No abnormal vascular lesions or secondary signs of brain AVM were observed. A brain AVM was first identified in October 2013. Bleeding occurred for the first time in February 2019 and occurred again in November 2019. The malformed vascular clusters progressed significantly during this period. No risk factors were associated with AVM in this case. Literature review revealed that most of the reported AVM cases had underlying pathology, and only a few of them had no cause of de novo AVM[5,8]. Our case report is the first to define the progression and eventual rupture within 6 years following its primary discovery. We also report for the first time that heterozygous mutations in the NOTCH2 gene might be playing a role in the pathogenesis of AVM. Currently, the pathogenesis of brain AVM is not clearly understood. The imbalance of some signal molecules during embryonic development is believed to be the most likely reason for no capillary formation between the arteries and veins[9]. This balance is dependent on the strict regulation of various angiogenic factors, and any interference for these automatic regulation factors may lead to the formation of AVM[10,11]. There was no high-risk factor for AVM in this case, and the only high-risk factor that may have a relation in the development of AVM was the heterozygous mutation of the NOTCH2 gene. The NOTCH2 protein is the receptor of the Notch signaling pathway, and its activity can directly affect Notch signaling[12]. However, the Notch signaling pathway has complex and context-dependent effects on angiogenesis[13,14]. Studies have demonstrated that abnormal activation of Notch signaling in human brain AVM was associated with AVM bleeding[15]. The inhibition and activation of Notch signaling were both associated with AVM formation. The mutation in this case (p.Asp473Val) was first described by Gilbert et al[16]. The mutation is located in exon 8, and exon 8 encodes the epidermal growth factor-12 domain of NOTCH2[16,17]. Unfortunately, there has been no research on the effect of this mutation on the function of the NOTCH2 protein.

CONCLUSION

We report for the first time a case of de novo AVM formation in a child, which progressed and eventually ruptured within 6 years. Our case contests the traditional view that brain AVM is congenital, and our case once again confirms the view that brain AVM is an acquired disease that is the result of an interaction of genes, environment, and molecules.

ACKNOWLEDGEMENTS

We thank the Department of Neurosurgery and the Department of Radiology of The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University for the diagnosis and treatment of the patient.
  17 in total

Review 1.  Notch signaling in vascular development and physiology.

Authors:  Thomas Gridley
Journal:  Development       Date:  2007-07-04       Impact factor: 6.868

Review 2.  Notch signaling and Notch signaling modifiers.

Authors:  Michael M Wang
Journal:  Int J Biochem Cell Biol       Date:  2011-08-12       Impact factor: 5.085

Review 3.  Pediatric de novo cerebral AVM: report of two cases and review of literature.

Authors:  Jared J Y Yeo; Sharon Y Y Low; Wan Tew Seow; David C Y Low
Journal:  Childs Nerv Syst       Date:  2014-12-24       Impact factor: 1.475

Review 4.  Pathogenesis and radiobiology of brain arteriovenous malformations: implications for risk stratification in natural history and posttreatment course.

Authors:  Achal S Achrol; Raphael Guzman; Monika Varga; John R Adler; Gary K Steinberg; Steven D Chang
Journal:  Neurosurg Focus       Date:  2009-05       Impact factor: 4.047

Review 5.  Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets.

Authors:  Wanqiu Chen; Eun-Jung Choi; Cameron M McDougall; Hua Su
Journal:  Transl Stroke Res       Date:  2014-04-12       Impact factor: 6.829

Review 6.  Embryological basis of some aspects of cerebral vascular fistulas and malformations.

Authors:  S Mullan; S Mojtahedi; D L Johnson; R L Macdonald
Journal:  J Neurosurg       Date:  1996-07       Impact factor: 5.115

7.  Arteriovenous Malformation in a Youth with Atypical Autism Symptoms.

Authors:  Veena Sison; Tracy Stackhouse; Robert Breeze; Terry Hall; Pamela McKenzie; Nicole Tartaglia
Journal:  J Child Dev Disord       Date:  2017-02-28

8.  Alagille syndrome mutation update: Comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification.

Authors:  Melissa A Gilbert; Robert C Bauer; Ramakrishnan Rajagopalan; Christopher M Grochowski; Grace Chao; Deborah McEldrew; James A Nassur; Elizabeth B Rand; Bryan L Krock; Binita M Kamath; Ian D Krantz; David A Piccoli; Kathleen M Loomes; Nancy B Spinner
Journal:  Hum Mutat       Date:  2019-08-26       Impact factor: 4.878

9.  N6-methyladenosine methyltransferase METTL3 affects the phenotype of cerebral arteriovenous malformation via modulating Notch signaling pathway.

Authors:  Lin-Jian Wang; Yimeng Xue; Ran Huo; Zihan Yan; Hongyuan Xu; Hao Li; Jia Wang; Qian Zhang; Yong Cao; Ji-Zong Zhao
Journal:  J Biomed Sci       Date:  2020-05-09       Impact factor: 8.410

Review 10.  'De Novo' Brain AVMs-Hypotheses for Development and a Systematic Review of Reported Cases.

Authors:  Ioan Alexandru Florian; Lehel Beni; Vlad Moisoiu; Teodora Larisa Timis; Ioan Stefan Florian; Adrian Balașa; Ioana Berindan-Neagoe
Journal:  Medicina (Kaunas)       Date:  2021-02-26       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.